BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31262236)

  • 1. Willingness to pay for QALY: perspectives and contexts in Japan.
    Igarashi A; Goto R; Yoneyama-Hirozane M
    J Med Econ; 2019 Oct; 22(10):1041-1046. PubMed ID: 31262236
    [No Abstract]   [Full Text] [Related]  

  • 2. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
    Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
    Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
    Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness to pay for a QALY.
    Gyrd-Hansen D
    Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.
    Pinto-Prades JL; Farreras V; de Bobadilla JF
    Eur J Health Econ; 2008 Feb; 9(1):69-78. PubMed ID: 17447095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation.
    Neumann PJ; Johannesson M
    Med Care; 1994 Jul; 32(7):686-99. PubMed ID: 8028404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?
    Shiroiwa T; Sung YK; Fukuda T; Lang HC; Bae SC; Tsutani K
    Health Econ; 2010 Apr; 19(4):422-37. PubMed ID: 19382128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
    Olofsson S; Norrlid H; Persson U
    J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
    Nimdet K; Ngorsuraches S
    BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.
    Byrne MM; O'malley K; Suarez-Almazor ME
    Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
    Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
    PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project.
    Baker R; Bateman I; Donaldson C; Jones-Lee M; Lancsar E; Loomes G; Mason H; Odejar M; Pinto Prades JL; Robinson A; Ryan M; Shackley P; Smith R; Sugden R; Wildman J;
    Health Technol Assess; 2010 May; 14(27):1-162. PubMed ID: 20525460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
    King JT; Tsevat J; Lave JR; Roberts MS
    Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WTP for a QALY and health states: More money for severer health states?
    Shiroiwa T; Igarashi A; Fukuda T; Ikeda S
    Cost Eff Resour Alloc; 2013; 11():22. PubMed ID: 24128004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for a QALY: theoretical and methodological issues.
    Gyrd-Hansen D
    Pharmacoeconomics; 2005; 23(5):423-32. PubMed ID: 15896094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of factors affecting willingness to pay for cardiovascular disease-related medical services.
    Yasunaga H; Ide H; Imamura T; Ohe K
    Int Heart J; 2006 Mar; 47(2):273-86. PubMed ID: 16607054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to pay for health care services in common cold, retinal detachment, and myocardiac infarction: an internet survey in Japan.
    Yasunaga H; Ide H; Imamura T; Ohe K
    BMC Health Serv Res; 2006 Feb; 6():12. PubMed ID: 16504017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating a WTP-based value of a QALY: the 'chained' approach.
    Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
    Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia.
    Shafie AA; Lim YW; Chua GN; Hassali MA
    Clinicoecon Outcomes Res; 2014; 6():473-81. PubMed ID: 25364267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.